These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11816844)

  • 1. CRF antagonists Dupont.
    Preti A
    Curr Opin Investig Drugs; 2001 Feb; 2(2):274-9. PubMed ID: 11816844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor antagonists: recent advances and exciting prospects for the treatment of human diseases.
    Gilligan PJ; Li YW
    Curr Opin Drug Discov Devel; 2004 Jul; 7(4):487-97. PubMed ID: 15338958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 8-(4-Methoxyphenyl)pyrazolo[1,5-a]-1,3,5-triazines: selective and centrally active corticotropin-releasing factor receptor-1 (CRF1) antagonists.
    Gilligan PJ; He L; Clarke T; Tivitmahaisoon P; Lelas S; Li YW; Heman K; Fitzgerald L; Miller K; Zhang G; Marshall A; Krause C; McElroy J; Ward K; Shen H; Wong H; Grossman S; Nemeth G; Zaczek R; Arneric SP; Hartig P; Robertson DW; Trainor G
    J Med Chem; 2009 May; 52(9):3073-83. PubMed ID: 19361210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists.
    Han X; Michne JA; Pin SS; Burris KD; Balanda LA; Fung LK; Fiedler T; Browman KE; Taber MT; Zhang J; Dubowchik GM
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3870-3. PubMed ID: 15990298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of 1,2,3,7-tetrahydro-6h-purin-6-one and 3,7-dihydro-1h-purine-2,6-dione derivatives as corticotropin-releasing factor(1) receptor antagonists.
    Hartz RA; Nanda KK; Ingalls CL; Ahuja VT; Molski TF; Zhang G; Wong H; Peng Y; Kelley M; Lodge NJ; Zaczek R; Gilligan PJ; Trainor GL
    J Med Chem; 2004 Sep; 47(19):4741-54. PubMed ID: 15341489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of potent, metabolically stable purine CRF-1 antagonists with differentiated binding kinetic profiles.
    Miller DC; Klute W; Brown AD
    Bioorg Med Chem Lett; 2011 Oct; 21(20):6108-11. PubMed ID: 21889333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotropin releasing factor antagonists--the new anti-anxiety magic bullets?
    Blessing WW
    Curr Opin Investig Drugs; 2001 Apr; 2(4):537-8. PubMed ID: 11566013
    [No Abstract]   [Full Text] [Related]  

  • 8. The CRF(1) receptor antagonist DMP696 produces anxiolytic effects and inhibits the stress-induced hypothalamic-pituitary-adrenal axis activation without sedation or ataxia in rats.
    McElroy JF; Ward KA; Zeller KL; Jones KW; Gilligan PJ; He L; Lelas S
    Psychopharmacology (Berl); 2002 Dec; 165(1):86-92. PubMed ID: 12474122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Robalzotan AstraZeneca.
    Mucke HA
    Curr Opin Investig Drugs; 2000 Oct; 1(2):236-40. PubMed ID: 11249580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of CRF1 receptor antagonists as antidepressants and anxiolytics: progress to date.
    Valdez GR
    CNS Drugs; 2006; 20(11):887-96. PubMed ID: 17044726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siramesine H Lundbeck.
    Heading C
    Curr Opin Investig Drugs; 2001 Feb; 2(2):266-70. PubMed ID: 11816842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of CRF but not NPY in the anxiety regulation via NMDA receptors.
    Wierońska JM; Szewczyk B; Pałucha A; Brański P; Smiałowska M
    Pol J Pharmacol; 2003; 55(6):1119-24. PubMed ID: 14730109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New class of corticotropin-releasing factor (CRF) antagonists: small peptides having high binding affinity for CRF receptor.
    Yamada Y; Mizutani K; Mizusawa Y; Hantani Y; Tanaka M; Tanaka Y; Tomimoto M; Sugawara M; Imai N; Yamada H; Okajima N; Haruta J
    J Med Chem; 2004 Feb; 47(5):1075-8. PubMed ID: 14971886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential uses of corticotropin-releasing hormone antagonists.
    Zoumakis E; Rice KC; Gold PW; Chrousos GP
    Ann N Y Acad Sci; 2006 Nov; 1083():239-51. PubMed ID: 17148743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anxiolytic-like effects of the corticotropin-releasing factor1 (CRF1) antagonist DMP904 [4-(3-pentylamino)-2,7-dimethyl-8-(2-methyl-4-methoxyphenyl)-pyrazolo-[1,5-a]-pyrimidine] administered acutely or chronically at doses occupying central CRF1 receptors in rats.
    Lelas S; Wong H; Li YW; Heman KL; Ward KA; Zeller KL; Sieracki KK; Polino JL; Godonis HE; Ren SX; Yan XX; Arneric SP; Robertson DW; Hartig PR; Grossman S; Trainor GL; Taub RA; Zaczek R; Gilligan PJ; McElroy JF
    J Pharmacol Exp Ther; 2004 Apr; 309(1):293-302. PubMed ID: 14742750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and biological activity of N-terminal lipidated and/or fluorescently labeled conjugates of astressin as corticotropin releasing factor antagonists.
    Rijkers DT; den Hartog JA; Liskamp RM
    Bioorg Med Chem; 2004 Oct; 12(19):5099-106. PubMed ID: 15351393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity studies on the corticotropin releasing factor antagonist astressin, leading to a minimal sequence necessary for antagonistic activity.
    Rijkers DT; Kruijtzer JA; van Oostenbrugge M; Ronken E; den Hartog JA; Liskamp RM
    Chembiochem; 2004 Mar; 5(3):340-8. PubMed ID: 14997526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule antagonists of the corticotropin releasing factor (CRF) receptor: recent medicinal chemistry developments.
    Tellew JE; Luo Z
    Curr Top Med Chem; 2008; 8(6):506-20. PubMed ID: 18397172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
    Lewis RT; Blackaby WP; Blackburn T; Jennings AS; Pike A; Wilson RA; Hallett DJ; Cook SM; Ferris P; Marshall GR; Reynolds DS; Sheppard WF; Smith AJ; Sohal B; Stanley J; Tye SJ; Wafford KA; Atack JR
    J Med Chem; 2006 Apr; 49(8):2600-10. PubMed ID: 16610803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonists.
    Arban R; Benedetti R; Bonanomi G; Capelli AM; Castiglioni E; Contini S; Degiorgis F; Di Felice P; Donati D; Fazzolari E; Gentile G; Marchionni C; Marchioro C; Messina F; Micheli F; Oliosi B; Pavone F; Pasquarello A; Perini B; Rinaldi M; Sabbatini FM; Vitulli G; Zarantonello P; Di Fabio R; St-Denis Y
    ChemMedChem; 2007 Apr; 2(4):528-40. PubMed ID: 17335099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.